Pricing Log in Create free account
Friday 6 November 2026 Export PBH’s income statement to Excel — free account

Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

43.06 1.26 −2.84%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Prestige Consumer Healthcare Inc. (PBH) Net margin

Alert me on Net margin

Prestige Consumer Healthcare Inc.'s net margin over the twelve months to 30 September 2026 was 13.3%, down 4.2 percentage points from fiscal 2026 (17.5%). Over the past ten years it has ranged from −7.30% (fiscal 2023) to 32.6% (fiscal 2018); the current reading is higher than 67% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of −2.45% and above the Healthcare sector median of 0.00%.

Net margin, annual

Embed this chart

Annual newest first

Period Net margin Change (points)
FY2026 17.5% (1.38)
FY2025 18.9% 0.26
FY2024 18.6% 25.90
FY2023 −7.30% (26.20)
FY2022 18.9% 1.44
FY2021 17.5% 2.69
FY2020 14.8% 18.44
FY2019 −3.67% (36.28)
FY2018 32.6% 24.74
FY2017 7.87% (4.52)

Quarterly newest first

Period Net margin Change (points)
Sep 2026 7.52% (3.46)
Jun 2026 11.0% (8.17)
Mar 2026 19.2% 2.68
Dec 2025 16.5% 1.07
43 more quarters

Against its own ten years

Low −7.30% High 32.6%
Ten-year median 16.1%
Current reading's percentile 40

Net margin against peers

Company Net margin
PBH Prestige Consumer Healthcare Inc. 13.3%
AMLX Amylyx Pharmaceuticals, Inc. compare 0.00%
RGC Regencell Bioscience Holdings Limited compare 0.00%
XERS Xeris Biopharma Holdings, Inc. compare −1.76%
HCM HUTCHMED (China) Limited Sponsored ADR compare −23.6%
BCRX BioCryst Pharmaceuticals, Inc. compare −37.4%
TRLV Trulieve Cannabis Corp. compare −41.2%
PRGO Perrigo Company plc compare −43.3%
ALVO Alvotech compare −101.1%
Drug Manufacturers Specialty & Generic industry median −2.45%
Healthcare sector median 0.00%
Market median 1.06%

What Net margin is

Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.

Net Income Allotted to Shareholders ÷ Revenue

The full definition of Net margin →

More on PBH